Becton Dickinson & Co (BDX)

BDX (NYSE:Health Services)
$125.73
pos +0.00
+0.00%
Today's Range: 124.98 - 125.87 | BDX Avg Daily Volume: 1,325,400
Last Update: 10/24/14 - 4:07 PM EDT
Volume: 0
YTD Performance: 13.79%
Open: $0.00
Previous Close: $125.00
52 Week Range: $104.60 - $130.21
Oustanding Shares: 191,835,949
Market Cap: 23,979,493,625
6-Month Chart
TheStreet Ratings Grade for BDX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 5 6 6
Moderate Buy 0 0 0 0
Hold 8 8 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 1 2 2
Mean Rec. 2.14 2.43 2.47 2.47
Latest Dividend: 0.54
Latest Dividend Yield: 1.80%
Dividend Ex-Date: 09/05/14
Price Earnings Ratio: 24.69
Price Earnings Comparisons:
BDX Sector Avg. S&P 500
24.69 25.40 28.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.11% 18.60% 60.72%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.50 0.09 0.03
Net Income 10.50 -0.21 -0.07
EPS 16.30 0.18 0.06
Earnings for BDX:
EBITDA 1.80B
Revenue 8.05B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (09/14) FY (09/15)
Average Estimate $1.65 $1.55 $6.24 $6.74
Number of Analysts 9 5 13 11
High Estimate $1.67 $1.58 $6.29 $6.86
Low Estimate $1.62 $1.48 $6.20 $6.60
Prior Year $1.58 $1.42 $5.95 $6.24
Growth Rate (Year over Year) 4.71% 9.15% 4.90% 7.97%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Kate Stalter

 | Oct 17, 2014 | 1:00 PM EDT

Hospitals, biotechs and drug makers continue to hold their own.

By

Kate Stalter

 | Oct 17, 2014 | 1:00 PM EDT

Hospitals, biotechs and drug makers are continuing to hold their own during this downturn.

By

David Katz

 | Oct 14, 2014 | 12:30 PM EDT

There may be a wave of consolidation.

By

Bob Byrne

 | Oct 8, 2014 | 7:30 AM EDT

The miners are untouchable.

bullishBecton Dickinson upgraded at Stifel

Oct 7, 2014 | 7:11 AM EDT

BDX was upgraded from Hold to Buy, Stifel Nicolaus said. $153 price target. Carefusion deal makes both financial and strategic sense.

By

Jim Cramer

 | Oct 6, 2014 | 3:30 PM EDT

Whatever you pick, it is hard to keep up with the S&P 500.

By

Doug Kass

 | Oct 6, 2014 | 8:10 AM EDT
Where it began.

bullishBecton Dickinson upgraded at JP Morgan

Oct 6, 2014 | 7:48 AM EDT

BDX was upgraded from Underweight to Neutral, JP Morgan said. $134 price target. Carefusion deal will add to earnings. 

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Jim Cramer

 | Jun 9, 2014 | 6:50 AM EDT

If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.

GS has cleared the important hurdle on the way up which increases the odds for an eventual...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher....
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sendin...
Market posting decent day considering Ebola getting headlines again. Believe investors ha...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.